Manulife Financial (MFC.TO)

It'll be range-bound. Doesn't see it moving much. Sooner or later, it'll rise up to its topside, which is 5-7% higher from now. A good stock for dividend collectors. Don't expect big moves or big returns.

Large life insurance in Canada. The Asian business is growing very nicely. The Hancock business in the US is not doing so well and, in his view, that is affecting the price of the stock. Still not very expensive. There is an opportunity to own this.

It has had a bit of a pull back. Lifecos do a bit better in a rising rate environment. They should start to do better. The balance sheet is in line and there is no problem there. It is fine in here.

They just changed management from a gentleman that 'steadied the ship'. The new one comes from managing operations in Asia. He expects new management looking at legacy assets that have held the company back. It is one of his primary holdings in the financial group. He thinks they will do well in a rising interest rate environment. They are much more present in Asia than any of the others. It is well capitalized.

Several months ago they brought in a new CEO and has yet to see a substantive change. He would prefer Sunlife or Great West Life instead.

Sees little or no impact on life insurance, including MFC's Asian operations, from a US trade war. Interest rate rise will help them. They have a good international growth profile, because of Asia. Generally, the Canadian lifecos look good. MFC is one of the few Canadian financials he owns.

A good company, but the stock price has been frustrating as it's stuck in a range given the John Hancock hangover in the U.S. MFC is trying to figure out what to do with it. When interest rates rise, MFC's stock will rise. Their Asian business is another tailwind.

He sees them as a black box in terms of how they price their contracts. They have complicated accounting and legacy-related challenges (such as the contracts written by John Hancock.) They have a new CEO and the new strategy is not yet clear. He prefers Intact Financial.

Manulife (MFC-T) versus Sunlife (SLF.T). He is not sure what the issue with Manulife might be. He holds Manulife in his RRSP and would buy more if it pulled back to $22.65. Sunlife is doing a good job and is way over-performing Manulife.

He owns SLF-T as well. He would more likely move from SLF-T into MFC-T rather than the other way. He is surprised it is performing a badly as it is. This is a good level to get into MFC-T and they are growing the dividend. It is good to hold them both in this rising rate environment.

He recently added at the $25 level. Their growth areas are in Asia and Canadian insurance, but face problems in the U.S. which accounts for the recent downturn in share price. They're grow their Asian assets and wealth management business. The stock will rise as interest rates do.

He does not hold this now, but it does rank highly due to its dividend. He thinks their business continues to ramp up going forward. On a total return and income perspective, it is good value. Yield 3.6%. (Analysts’ price target is $30 )

Buy at $24.50 today and hold it for the dividend? It's not exactly a growth story, but they may sell parts of John Hancock which may translate into dividend increases. Don't step into it now, but hold it. It hasn't grown as much as she'd like. That said, the CEO will make changes to benefit the company.

Since 2007 it is the only financial that is still down from its peak. It has the most room for improvement. They have the ability to resolve all their issues and get the stock up. If he was going to buy a lifeco it would be this one.

(A Top Pick Feb. 1/17, Up 3%) It will do better in a rising interest rate environment. They've restructured since the financial sheet, and their balance sheet is much stronger. Strong, growing Asian operation is quite profitable. The new CEO will address their legacy businesses which have dragged on earnings. Bullish about lifecos, but MFC would be his top pick.